BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28646013)

  • 1. Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational
    Bauckneht M; Ferrarazzo G; Fiz F; Morbelli S; Sarocchi M; Pastorino F; Ghidella A; Pomposelli E; Miglino M; Ameri P; Emionite L; Ticconi F; Arboscello E; Buschiazzo A; Massimelli EA; Fiordoro S; Borra A; Cossu V; Bozzano A; Ibatici A; Ponzoni M; Spallarossa P; Gallamini A; Bruzzi P; Sambuceti G; Marini C
    J Nucl Med; 2017 Oct; 58(10):1638-1645. PubMed ID: 28646013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline.
    Sarocchi M; Bauckneht M; Arboscello E; Capitanio S; Marini C; Morbelli S; Miglino M; Congiu AG; Ghigliotti G; Balbi M; Brunelli C; Sambuceti G; Ameri P; Spallarossa P
    J Transl Med; 2018 Oct; 16(1):295. PubMed ID: 30359253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [
    Seiffert AP; Gómez-Grande A; Castro-Leal G; Rodríguez A; Palomino-Fernández D; Gómez EJ; Sánchez-González P; Bueno H
    Int J Comput Assist Radiol Surg; 2022 Feb; 17(2):373-383. PubMed ID: 34698987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity.
    Kim J; Cho SG; Kang SR; Yoo SW; Kwon SY; Min JJ; Bom HS; Song HC
    J Nucl Cardiol; 2020 Dec; 27(6):2154-2163. PubMed ID: 30719656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced Cardiac18F-FDG Uptake in Patients with Lymphoma: An Early Metabolic Index of Cardiotoxicity?
    Dourado MLC; Dompieri LT; Leitão GM; Mourato FA; Santos RGG; Almeida Filho PJ; Markman Filho B; Melo MDT; Brandão SCS
    Arq Bras Cardiol; 2022; 118(6):1049-1058. PubMed ID: 35703659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Myocardial Metabolic Abnormalities by 18F-FDG PET/CT and Corresponding Pathological Changes in Beagles with Local Heart Irradiation.
    Yan R; Song J; Wu Z; Guo M; Liu J; Li J; Hao X; Li S
    Korean J Radiol; 2015; 16(4):919-28. PubMed ID: 26175594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
    Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M
    Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Score-Based Approach to
    Bauckneht M; Morbelli S; Fiz F; Ferrarazzo G; Piva R; Nieri A; Sarocchi M; Spallarossa P; Canepari ME; Arboscello E; Bellodi A; Massaia M; Gallamini A; Bruzzi P; Marini C; Sambuceti G
    Diagnostics (Basel); 2017 Oct; 7(4):. PubMed ID: 29072629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity.
    Sivapackiam J; Kabra S; Speidel S; Sharma M; Laforest R; Salter A; Rettig MP; Sharma V
    PLoS One; 2019; 14(5):e0215579. PubMed ID: 31120912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection.
    Gaeta C; Fernández Y; Pavía J; Flotats A; Artigas C; Deportos J; Geraldo L; Carrió I
    Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2018-24. PubMed ID: 21739330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
    Manabe O; Yoshinaga K; Ohira H; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Masuda A; Magota K; Nishimura M; Tamaki N
    Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
    Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
    J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice.
    Wong KP; Sha W; Zhang X; Huang SC
    J Nucl Med; 2011 May; 52(5):800-7. PubMed ID: 21498533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?
    Borde C; Kand P; Basu S
    World J Radiol; 2012 May; 4(5):220-3. PubMed ID: 22761982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.